111 related articles for article (PubMed ID: 29046151)
1. Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers.
Cavalli R; Marano F; Argenziano M; Varese A; Frairia R; Catalano MG
Curr Drug Deliv; 2018; 15(6):752-754. PubMed ID: 29046151
[No Abstract] [Full Text] [Related]
2. Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid Cancer.
Marano F; Argenziano M; Frairia R; Adamini A; Bosco O; Rinella L; Fortunati N; Cavalli R; Catalano MG
Thyroid; 2016 May; 26(5):705-16. PubMed ID: 26906083
[TBL] [Abstract][Full Text] [Related]
3. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model.
Marano F; Frairia R; Rinella L; Argenziano M; Bussolati B; Grange C; Mastrocola R; Castellano I; Berta L; Cavalli R; Catalano MG
Endocr Relat Cancer; 2017 Jun; 24(6):275-286. PubMed ID: 28487350
[TBL] [Abstract][Full Text] [Related]
4. Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.
Marano F; Rinella L; Argenziano M; Cavalli R; Sassi F; D'Amelio P; Battaglia A; Gontero P; Bosco O; Peluso R; Fortunati N; Frairia R; Catalano MG
PLoS One; 2016; 11(12):e0168553. PubMed ID: 28002459
[TBL] [Abstract][Full Text] [Related]
5. Intelligent phototriggered nanoparticles induce a domino effect for multimodal tumor therapy.
Xu X; Han C; Zhang C; Yan D; Ren C; Kong L
Theranostics; 2021; 11(13):6477-6490. PubMed ID: 33995669
[No Abstract] [Full Text] [Related]
6. NIR-Laser-Controlled Drug Release from DOX/IR-780-Loaded Temperature-Sensitive-Liposomes for Chemo-Photothermal Synergistic Tumor Therapy.
Yan F; Duan W; Li Y; Wu H; Zhou Y; Pan M; Liu H; Liu X; Zheng H
Theranostics; 2016; 6(13):2337-2351. PubMed ID: 27877239
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles.
Nittayacharn P; Yuan HX; Hernandez C; Bielecki P; Zhou H; Exner AA
J Pharm Sci; 2019 Sep; 108(9):3091-3098. PubMed ID: 31095958
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
9. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
[TBL] [Abstract][Full Text] [Related]
10. Nano-Carriers of Combination Tumor Physical Stimuli-Responsive Therapies.
Jin W; Dong C; Yang D; Zhang R; Jiang T; Wu D
Curr Drug Deliv; 2020; 17(7):577-587. PubMed ID: 32448102
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
Song Y; Tang C; Yin C
Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
[TBL] [Abstract][Full Text] [Related]
14. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
[TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Vivo Evaluation of Targeted Sunitinib-Loaded Polymer Microbubbles Against Proliferation of Renal Cell Carcinoma.
Hu J; Zong Y; Li J; Zhou X; Zhang J; Zhu T; Jiao M; Su H; Bo B
J Ultrasound Med; 2016 Mar; 35(3):589-97. PubMed ID: 26921089
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobically modified polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugs.
Jung B; Shim MK; Park MJ; Jang EH; Yoon HY; Kim K; Kim JH
Int J Pharm; 2017 Mar; 520(1-2):111-118. PubMed ID: 28179099
[TBL] [Abstract][Full Text] [Related]
18. Genetically Engineered Plasma Membrane Nanovesicles for Cancer-Targeted Nanotheranostics.
Zhang P; Chen H; Liu J; Liu G
Methods Mol Biol; 2019; 2054():283-294. PubMed ID: 31482462
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and efficacy of doxorubicin-loaded plant virus nanoparticles in preclinical models of cancer.
Madden AJ; Oberhardt B; Lockney D; Santos C; Vennam P; Arney D; Franzen S; Lommel SA; Miller CR; Gehrig P; Zamboni WC
Nanomedicine (Lond); 2017 Oct; 12(20):2519-2532. PubMed ID: 28952882
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species activated nanoparticles with tumor acidity internalization for precise anticancer therapy.
Deng H; Zhao X; Deng L; Liu J; Dong A
J Control Release; 2017 Jun; 255():142-153. PubMed ID: 28385677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
